Max Lehmann
University of Erlangen-Nuremberg
2 Papers
Max Lehmann is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Cancer & SDHA. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Association of cancer metabolism-related proteins with oral carcinogenesis – indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
Martin Grimm,Marcel Cetindis,Max Lehmann,Thorsten Biegner,Adelheid Munz,Peter Teriete,Wiebke Kraut,Siegmar Reinert +7 more
TL;DR: This study provides the first evidence of the expression of IGF-R1, glycolysis-related proteins GLUT- 1, HK 2, PFK-1, LDHA, and TKTL1, as well as mitochondrial enzymes SDHA, SDHB, and ATP synthase in the multi-step carcinogenesis of OSCC.
Apoptosis resistance-related ABCB5 and DNaseX (Apo10) expression in oral carcinogenesis.
Martin Grimm,Marcel Cetindis,Max Lehmann,Thorsten Biegner,Adelheid Munz,Peter Teriete,Siegmar Reinert +6 more
TL;DR: Overcoming drug resistance of ABCB5+ and Apo10+ cells in precursor lesions and tumors by natural compounds may act as sensitizers for apoptosis or could be useful for chemoprevention.
15